MedTrace Logo

The Development and Validation of the Arabic Otago Exercise Program

NCT05002803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-04-07

No results posted yet for this study

Summary

Falls are common in older adults and may lead to disability or even death. Therefore, exercise programs that focus on preventing falls by improving strength and balance are important to investigate in older adults. One of the home-based exercise programs that was found effective in reducing the risk of falling and the rate of subsequent falls in older adults is the Otago exercise program (OEP). The OEP is an individualized home based retraining program that works mainly on balance and lower extremity strength through several progressive resistive exercises.

The OEP is available in English language since late 1990. However, its use in the Arabic-speaking countries is limited due to the language barrier. Therefore, translating such a program to the Arabic language would facilitate its use among Arabic-speaking older adults.

Therefore, this study aims:

* To translate the Otago Exercise Program (OEP) into the Arabic language.
* To assess the feasibility of the Arabic OEP in a pilot sample of Arabic-speaking older adults.

Conditions

  • Older Adults

Interventions

OTHER

Otago Exercise Program

A Home-based Exercise Program to improve strength and balance and prevent falls.

Sponsors & Collaborators

  • University of Jordan

    lead OTHER

Principal Investigators

  • Alia A. Alghwiri, PhD · University of Jordan

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05002803 on ClinicalTrials.gov